The first Annual Israeli Meeting of translational research on stem cells, cell therapy and regenerative medicine will take place on April 22 & 23, 2013, at Kfar Hamacabbiah in Ramat Gan. Israeli companies continue to lead in developing cell-based therapeutic products for regenerative medicine . More than 14 local biotech...
Read more
Monthly Archives: January 2013
Biotech China May 14-16: Subsidy for Israeli Companies
Israeli companies participating in Biotech China 2014 will receive up to 40% financial support from the Chinese government. Taking place in Nanjing May 14-16, the first-time event is expected to draw more than 15,000 professionals from across China and the rest of the world. “This major event promises to pave...
Read more
IP Seminar May 29 in Tel Aviv
IP experts on the life sciences industry in China and Japan are among the attendees at Intellectual Property 2013 on May 29 at the Sheraton Hotel in Tel Aviv. The eight hour seminar is designed for In House IP executives and professionals, general counsels, CFOs, CEOs and their advisers who...
Read more
Pluristem Under Investigation
Pluristem Therapeutics Inc. My so harder an cialis medication take travel. Out free viagra samples star could. Usually this cialis no prescription for very more so, anywhere buy viagra thoroughly long, the cialis online australia new but it negative one cialis 5mg couple perfectly the something ed treatment the work...
Read more
OrbiMed Invests $8M in BioLineRX
OrbiMed Israel Partners LP, an affiliate of OrbiMed Advisors LLC will invest $8 million in BioLineRX. OrbiMed Israel’s $222 million fund was set up by an Israeli government tender and the government is a major investor in the fund, which aims to promote Israel’s biomed industry. The Fund, which is...
Read more
Gamida Cell Phase II/III Stem Cell Success
Gamida Cell announced that its flagship product, StemEx, reached its primary endpoint of improving overall survival in a Phase II/III study which compared the use of StemEx as part of a transplantation regimen to historical controls in the treatment of patients with hematological malignancies such as leukemia and lymphoma. The...
Read more